C3.ai(US:AI) Globenewswireยท2025-10-20 13:40Core Viewpoint - The C3.ai class action lawsuit alleges that the company and its executives misled investors regarding the company's revenue outlook and growth potential, particularly in relation to CEO Thomas M. Siebel's health concerns, which ultimately led to a significant drop in stock price following disappointing financial results [1][4][5]. Group 1: Lawsuit Details - The lawsuit is titled Liggett v. C3.ai, Inc., No. 25-cv-07129, and is pending in the Northern District of California, representing purchasers or acquirers of C3.ai securities [1]. - The lawsuit claims that C3.ai's optimistic reports on growth and profitability were misleading and overly reliant on the health of its CEO [4]. - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal year 2026 and reduced its revenue guidance for the full fiscal year, attributing these issues to leadership reorganization and the CEO's health, resulting in a stock price drop of over 25% [5]. Group 2: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased C3.ai securities during the Class Period to seek appointment as lead plaintiff, representing the interests of the class [6]. - The lead plaintiff is typically the investor with the greatest financial interest in the case and can select a law firm to litigate the lawsuit [6]. Group 3: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading firm in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [7]. - The firm has been ranked 1 in the ISS Securities Class Action Services rankings for four out of the last five years, indicating its prominence in the field [7].